PremiumCompany AnnouncementsAstraZeneca’s DEBATE Study Signals Long‑Term Bet on Precision Sinus Care1d agoAZN
PremiumThe FlyRoyalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront1d agoAZNRPRX
PremiumThe FlyTrump to set 100% tariff on generic drugs brought into U.S. starting in 20282d agoAZNBMY